Subscribe to RSS
DOI: 10.1055/s-0029-1246197
© Georg Thieme Verlag KG Stuttgart · New York
Postsplenectomy Sepsis in Splenectomized, Partially Splenectomized and Non-splenectomized Rats after Streptococcus Pneumoniae Challenge
Publication History
received November 11, 2009
accepted after revision December 01, 2009
Publication Date:
09 April 2010 (online)

Abstract
Introduction: Purpose of the study was the evaluation of the role of 1/3 of the spleen in host defense after a challenge with Streptococcus pneumoniae.
Materials and methods: Forty Wistar rats divided into four groups underwent splenectomy (SPR), partial splenectomy (PSR) or sham operation (SOR). Healthy rats were used as controls (CGR). Operations were performed under general anesthesia. Ten weeks after operation the rats were challenged with 6×107 cfu/ml Streptococcus pneumoniae administered intravenously. All surviving animals were sacrificed 12 days after intravenous injection Interleukin-10, tumor necrosis factor-α and human β-defensin-2 containing cells were detected in the parenchymatous organs (spleen, lungs, liver and kidneys) of all groups. Kaplan-Meier and Mann-Whitney tests were used for statistical analysis.
Results: Survival after Streptococcus pneumoniae challenge was longer in animals with a greater amount of splenic tissue, with mortality increased proportionately to the reduction in splenic tissue. In the SOR group survival was 11.6±1.3 days (10% mortality). In the PSR group survival was 6.0±2.5 days (90% mortality). In the SPR group survival was 1.6±0.8 days (100% mortality). In splenic tissue the levels of HβD-2, IL-10 and TNF-α-containing cells did not differ statistically (z=5.021; p<0.01) and were higher than in other parenchymatous organs (PSR, SOR, CGR). Levels of IL-10-containing cells were higher in parenchymatous organs of the SPR group (z=7.919; p<0.001), similar in the PSR and SOR groups (z=1.020; p=0.308) and lower in the CGR group (z=4.366; p<0.01). There were no statistically significant differences in the levels of IL-10 containing cells in the lungs of all group rats with spleen (z=4.266; p<0.01). Levels of TNF-α-containing cells were similar in PSR and SOR groups (z=1.004; p=0.315). Relative levels of HβD-2 in kidney differed between all groups (z=2.916; p=0.004).
Conclusions: All of the splenectomized animals (100%) and 90% of the partially splenectomized animals died. Partial splenectomy (with 1/3 of splenic tissues remaining) does not offer full protection against Streptococcus pneumoniae sepsis. In all groups, the amounts of HβD-2, IL-10 and TNF-α-containing cells in the spleen were higher than in other parenchymatous organs (lungs, liver and kidneys).
Key words
postsplenectomy sepsis - splenectomy - partial splenectomy - rats
References
- 1 Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall; 1999: 611
MissingFormLabel
- 2
Anderson R, Alwmark A, Bengmark S.
Influence of dextran on pneumococcal septicemia in splenic artery-ligated or splenectomized
rats.
Res Exp Med.
1987;
187
423-427
MissingFormLabel
- 3
Braithwaite JL, Adams DJ.
The venous drainage of the rat spleen.
J Anat.
1957;
91
352-357
MissingFormLabel
- 4
Chong TC, Thangavel RR, Tang X.
Enhanced expression of murine β- defensins (MBD-1,-2,-3 and -4) in upper and lower
airway mucosa of influenza virus infected mice.
J Virology.
2008;
DOI: doi:10.1016/j.virol.2008.07.024
MissingFormLabel
- 5
Hegarty PK, Tan B, O’Sullivan R. et al .
Prevention of postsplenectomy sepsis: how much do patients know?.
Hematology J.
2000;
1
357-359
MissingFormLabel
- 6
Hsu SM, Raine L, Fanger H.
The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase
technics.
Am J Clin Pathol.
1981;
75
816-821
MissingFormLabel
- 7
Kaufman S, Levasseur J.
Effect of portal hypertension on splenic blood flow, intrasplenic extravasation and
systemic blood pressure.
Am J Physiol Regul Integr Comp Physiol.
2003;
284
R1580-R1585
MissingFormLabel
- 8
Kaur K, Dhingra S, Slezak J.
Biology of TNF-α and IL-10, and their imbalance in heart failure.
Heart Fail Rev.
2008;
doi 10.1007/s10741-008-9104-z
MissingFormLabel
- 9
Kimura F, Itoh H, Ambiru S.
Long-term results of initial and repeated partial splenic embolization for the treatment
of chronic idiopathic thrombocytopenic purpura.
AJR Am J Roentgenol.
2002;
179
1323-1326
MissingFormLabel
- 10
Lee HY, Andalibi A, Webster P. et al .
Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.
BMC Infect Dis.
2004;
4
12
MissingFormLabel
- 11
Livingston CD, Barray A. et al .
Penicillin and natural immunity protect against postsplenectomy sepsis.
J Surg Research.
1983;
34
332-336
MissingFormLabel
- 12
Mendez-Samperio P, Miranda E, Trejo A.
Regulation of human β-defensin-2 by Mycobacterium bovis bacillus Calmette-Guerin (BCG):
involvement of PFC, JNK and P13 in human lung epithelial cell line (A549).
J Peptides.
2008;
DOI: doi:10.1016/j.peptides.05.019
MissingFormLabel
- 13
Muftuogly T, Koksal N, Ozkultu D.
Evalution of phagocytic function of macrophages in rats after partial splenectomy.
J Am Coll Surg.
2000;
191
668
MissingFormLabel
- 14
Nio M, Hayashi Y, Sano N. et al .
Long-term efficacy of partial splenic embolization in children.
J Pediatr Surg.
2003;
38
1760-1762
MissingFormLabel
- 15
Offenbartl K, Christensen P, Gullstrand P.
Treatment of pneumococcal postsplenectomy sepsis in the rat with human γ-globulin.
J Surg Research.
1986;
40
198-201
MissingFormLabel
- 16
Petersons A, Volrats O, Bernsteins A.
The first experience with non-operative treatment of hypersplenism in children with
portal hypertension.
Eur J Pediatr Surg.
2002;
12
289-360
MissingFormLabel
- 17
Pratl B, Benesch M, Lackner H. et al .
Partial splenic embolization in children with hereditary spherocytosis.
Eur J Haematol.
2008;
80
76-80
MissingFormLabel
- 18 Riffenburgh RH. Statistics in Medicine. Amsterdam: Elsevier Academic Press; 2006: 322
MissingFormLabel
- 19
Scher KS, Wroczynski AF, Jones CW.
Protection from postsplenectomy sepsis: Effect of prophylactic penicillin and pneumococcal
vaccine on clearance of type 3 pneumococcus.
Surgery.
1982;
93
792-797
MissingFormLabel
- 20
Singh PK, Jia HP, Wiles K. et al .
Production of β-defensins by human airway epithelia.
Proc Natl Acad Sci.
1998;
95
14961-14966
MissingFormLabel
- 21
Torres MB, Vega VL, Bedri M.
IL-10 plasma levels are elevated after LPS injection in splenectomized A/J mice.
J Surg Res.
2005;
129
101-106
MissingFormLabel
- 22
van der Poll TA, Marchant A, Keogh CV. et al .
Interleukin-10 impairs host defense in murine pneumococcal pneumonia.
J Infect Dis.
1996;
174
994
MissingFormLabel
- 23
van der Sluijs KF, Elden LJR, Nijhuis M. et al .
IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia
after influenza infection.
J Immunol.
2004;
15
((172))
7603-7609
MissingFormLabel
- 24
Yuang D, Biragyn A, Kwak LW. et al .
Mammalian defensins in immunity: more than just microbicidal.
Trends Immunol.
2002;
23
291-296
MissingFormLabel
- 25
Zhu K, Meng X, Li Z. et al .
Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in
cirrhosis: a prospective randomized study.
Eur J Radiol.
2008;
66
100-106
MissingFormLabel
Correspondence
Dr. Olaf Volrats
University Children's Hospital
Pediatrics Surgery
Vienibas gatve 45
LV-1004 Riga
Latvia
Phone: +371 29477212
Fax: +371 67064473
Email: olafsvolrats@hotmail.com